Sharescart Research Club logo
Apollo Green 60 (-3.2%)Axles India 525 (6.1%)Bira 108 (0%)CIAL 438 (0%)CSK 268 (8.1%)ESDS Software 448 (-3.7%)Garuda Aerospace 485 (-2%)GFCL EV 42 (0%)HDFC Securities 8950 (-0.6%)Hella Infra 110000 (-2.2%)Hero Fincorp 1075 (2.4%)HPX India 29 (11.5%)Incred Holdings 152 (-1.3%)India Carbon 895 (0%)Indian Potash 2850 (1.8%)Inox Clean 725 (-8.8%)Insolare Energy 185 (0%)Matrix Gas 16 (0%)Motilal Oswal 12.95 (17.7%)MSEI 6.25 (-7.4%)Nayara Energy 1200 (0%)NCDEX 398 (-1.7%)NeRL 58 (0%)NSE 1965 (3.7%)Onix Renewable 68 (17.2%)Orbis Financial 408 (0.7%)OYO 24 (0%)Pharmeasy 6.25 (-3.8%)Polymatech Electronics 62 (-3.1%)RRP S4E 168 (-15.2%)SBI Mutual 775 (0%)Ticker Ltd 32 (0%)Zepto 49 (-9.3%)

15 Days Price Change

Magenta Lifecare IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 35  to  35 per share
Profile
Min Investment ₹35
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Magenta Lifecare Limited is a dynamic healthcare company specializing in providing innovative medical solutions. With a commitment to enhancing the quality of life, Magenta Lifecare offers a comprehensive range of pharmaceutical products, medical devices, and health supplements. The company emphasizes rigorous research and development to ensure the efficacy and safety of its products, aligning with global standards. Magenta Lifecare's portfolio includes advanced therapies for various medical conditions, catering to both domestic and international markets. By fostering strong partnerships with healthcare professionals and institutions, the company aims to deliver accessible and affordable healthcare solutions. Through its dedication to excellence and continuous innovation, Magenta Lifecare Limited aspires to be a leader in the healthcare industry, improving patient outcomes and contributing to a healthier society. Read More

Basic Info

Face Value 10 per share

Price 35  to  35 per share

P/E (x) 350

Sales( Cr.) 10

PAT( Cr.) 0

EPS 0.1

Draft Prospectus --

Exchange BSE-SME

Promoter

Company Promoters

Divyesh Modi Khyati Modi

Pre Issue Share Holding 84.06%

Post Issue Share Holding 59.59%

Listing Details:

Listing Price: 45

Listing Gain: 22.22%

Current Price: 11.1

Gain On Issue: 11.1 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Jun 05, 2024
Closing Date Jun 07, 2024
Allotment Jun 10, 2024
Refund Jun 11, 2024
Delivery of Shares Jun 11, 2024
Listing Date Jun 12, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 4000 140,000
Retail (Max) 1 4000 140,000
S-HNI (Min) 2 8000 280,000
S-HNI (Max) 7 28000 980,000
B-HNI (Min) 8 32000 1,120,000

Objective of the Issue

1. Funding our working capital requirements 2. General corporate purposes

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 1000000 1145780000 1145.8x
Retail 1000000 778410000 778.4x
EMP 0 0 0x
Total 2000000 1966380000 983.2x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Magenta Lifecare Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 10 9 9 9 10
Other Income 0 0 0 0 1
Total Income 10 9 10 9 11
Total Expenditure 9 8 8 7 10
Operating Profit 1 1 1 2 1
Interest 1 1 1 1 0
Depreciation 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 0 0 0 1 0
Provision for Tax -0 0 0 0 -0
Profit After Tax 0 0 0 1 0
Adjustments 0 0 0 0 0
Profit After Adjustments 0 0 0 1 0
Adjusted Earnings Per Share 0.5 0.4 0.5 1.5 0.1

Magenta Lifecare Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 1 4 5 7 14
Minority's Interest 0 0 0 0 0
Borrowings 6 3 1 1 0
Other Non-Current Liabilities -0 0 0 0 -0
Total Current Liabilities 7 7 7 5 4
Total Liabilities 15 14 13 13 18
Fixed Assets 2 2 2 2 2
Other Non-Current Assets 2 2 2 2 2
Total Current Assets 10 10 9 10 14
Total Assets 15 14 13 13 18

Magenta Lifecare Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 0
Cash Flow from Operating Activities 1 1 2 -1 -4
Cash Flow from Investing Activities -0 -0 -0 -0 -0
Cash Flow from Financing Activities -1 -1 -2 1 6
Net Cash Inflow / Outflow 0 0 0 -0 1
Closing Cash & Cash Equivalent 0 0 0 0 1

Magenta Lifecare Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.53 0.44 0.53 1.52 0.12
CEPS(Rs) 1.08 0.92 0.97 1.93 0.41
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 2.54 7.32 11.26 14.04 19.38
Core EBITDA Margin(%) 10.81 11.5 9.63 17.09 -0.44
EBIT Margin(%) 8.91 10.83 12.75 18.01 3.34
Pre Tax Margin(%) 1.82 2.45 3.49 11.66 0.66
PAT Margin (%) 2.02 2.04 2.71 8.43 0.81
Cash Profit Margin (%) 4.08 4.23 4.96 10.75 2.8
ROA(%) 1.33 1.31 1.84 5.78 0.53
ROE(%) 20.94 9.34 5.9 12.26 0.82
ROCE(%) 8 9.34 11.32 15.91 2.68
Receivable days 127.12 118.1 81.12 72.44 117.25
Inventory Days 233.11 250.67 267.51 292.84 265.81
Payable days 118.94 113.91 129.06 165.4 96.14
PER(x) 0 0 0 0 112.37
Price/Book(x) 0 0 0 0 0.7
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 1.12 0.94 0.63 0.91 0.97
EV/Core EBITDA(x) 10.18 7.19 4.21 4.46 18.17
Net Sales Growth(%) 0 -4.18 -1.92 -3.35 16.21
EBIT Growth(%) 0 16.43 15.45 36.51 -78.42
PAT Growth(%) 0 -2.83 30.02 200.69 -88.79
EPS Growth(%) 0 -16.51 19.71 185.7 -92.05
Debt/Equity(x) 10.58 2.43 0.87 0.48 0.15
Current Ratio(x) 1.35 1.33 1.31 1.95 3.52
Quick Ratio(x) 0.51 0.42 0.28 0.47 1.56
Interest Cover(x) 1.26 1.29 1.38 2.84 1.25
Total Debt/Mcap(x) 0 0 0 0 0.22

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 11% 4% 0% 0%
Operating Profit CAGR -50% 0% 0% 0%
PAT CAGR -100% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -38% NA% NA% NA%
ROE Average 1% 6% 10% 10%
ROCE Average 3% 10% 9% 9%

Company Contact Information

Magenta Lifecare Ltd.

N P Patel Estate A & T Padamla

IPO Lead Manager(s)

Magenta Lifecare Ltd.

Fedex Securities Ltd.

Registrar Info

Magenta Lifecare Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp